Checkmate Pharmaceuticals, Inc. EPS - Earnings per Share 2020-2022 | CMPI
Checkmate Pharmaceuticals, Inc. eps - earnings per share from 2020 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Checkmate Pharmaceuticals, Inc. Annual EPS |
| 2021 |
$-2.84 |
| 2020 |
$-4.49 |
| 2019 |
$-24.16 |
| 2018 |
$-18.14 |
| Checkmate Pharmaceuticals, Inc. Quarterly EPS |
| 2022-03-31 |
$-0.73 |
| 2021-12-31 |
$-0.62 |
| 2021-09-30 |
$-0.69 |
| 2021-06-30 |
$-0.88 |
| 2021-03-31 |
$-0.65 |
| 2020-12-31 |
$10.17 |
| 2020-09-30 |
$-0.84 |
| 2020-06-30 |
$-7.37 |
| 2020-03-31 |
$-6.45 |
| 2019-12-31 |
$-6.48 |
| 2019-09-30 |
$-5.75 |
| 2019-06-30 |
$-5.88 |
| 2019-03-31 |
$-6.05 |
